Startseite UR

Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

Heidemann, E., Stoeger, H., Souchon, R., Hirschmann, W.-D., Bodenstein, H., Oberhoff, C., Fischer, J. T., Schulze, M., Clemens, M., Andreesen, Reinhard, Mahlke, M., König, M., Scharl, A., Fehnle, K. und Kaufmann, M. (2002) Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 13 (11), S. 1717-29.

Im Publikationsserver gibt es leider keinen Volltext zu diesem Eintrag.

Zum PubMed-Eintrag dieses Artikels


Zusammenfassung

BACKGROUND: To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment. PATIENTS AND METHODS: A total of 260 women with measurable metastatic breast cancer fulfilling high-risk criteria, previously untreated with chemotherapy for their metastatic disease, were randomized to receive either mitoxantrone 12 mg/m(2) or the ...

plus


Bibliographische Daten exportieren



Dokumentenart:Artikel
Datum:2002
Institutionen:Medizin > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Identifikationsnummer:
WertTyp
12419743PubMed-ID
Klassifikation:
NotationArt
AdultMESH
AgedMESH
Antineoplastic Combined Chemotherapy Protocols/therapeutic useMESH
Biopsy, NeedleMESH
Bone Neoplasms/secondaryMESH
Breast Neoplasms/pathologyMESH
Cyclophosphamide/administration & dosageMESH
Disease-Free SurvivalMESH
Epirubicin/administration & dosageMESH
FemaleMESH
Fluorouracil/administration & dosageMESH
GermanyMESH
HumansMESH
Liver Neoplasms/secondaryMESH
Logistic ModelsMESH
Lung Neoplasms/secondaryMESH
Middle AgedMESH
Mitoxantrone/administration & dosageMESH
Neoplasm StagingMESH
ProbabilityMESH
Proportional Hazards ModelsMESH
Quality of LifeMESH
Risk AssessmentMESH
Sensitivity and SpecificityMESH
Statistics, NonparametricMESH
Survival AnalysisMESH
Treatment OutcomeMESH
Dewey-Dezimal-Klassifikation:600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
Status:Veröffentlicht
Begutachtet:Ja, diese Version wurde begutachtet
An der Universität Regensburg entstanden:Ja
Eingebracht am:20 Apr 2010 06:20
Zuletzt geändert:08 Mrz 2017 08:26
Dokumenten-ID:14412
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de

Dissertationen: dissertationen@ur.de

Forschungsdaten: daten@ur.de

Ansprechpartner